Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study
Titel:
Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study
Auteur:
Danese, Silvio Colombel, Jean-Frederic Lukas, Milan Gisbert, Javier P D'Haens, Geert Hayee, Bu'hussain Panaccione, Remo Kim, Hyun-Soo Reinisch, Walter Tyrrell, Helen Oh, Young S Tole, Swati Chai, Akiko Chamberlain-James, Kirsten Tang, Meina Tao Schreiber, Stefan